Biktarvy, formally known as bictegravir sulfate, is a effective single-tablet treatment for treating HIV infection. This drug unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to copy within the body, considerably lowering the viral quantity. For many indivi